vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and Velocity Financial, Inc. (VEL). Click either name above to swap in a different company.
Cytek Biosciences, Inc. is the larger business by last-quarter revenue ($62.1M vs $51.6M, roughly 1.2× Velocity Financial, Inc.). Velocity Financial, Inc. runs the higher net margin — 67.3% vs -70.9%, a 138.3% gap on every dollar of revenue. On growth, Velocity Financial, Inc. posted the faster year-over-year revenue change (32.8% vs 8.1%). Velocity Financial, Inc. produced more free cash flow last quarter ($17.9M vs $-1.8M). Over the past eight quarters, Velocity Financial, Inc.'s revenue compounded faster (32.3% CAGR vs 17.7%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
Velocity Financial, Inc. is a U.S.-headquartered real estate finance company that offers specialized mortgage loan solutions primarily for residential investment properties. It partners with independent mortgage brokers nationwide, providing real estate investors with short-term bridge loans and long-term rental property financing options tailored to their operational needs.
CTKB vs VEL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $51.6M |
| Net Profit | $-44.1M | $34.8M |
| Gross Margin | 52.9% | — |
| Operating Margin | -9.0% | 97.0% |
| Net Margin | -70.9% | 67.3% |
| Revenue YoY | 8.1% | 32.8% |
| Net Profit YoY | -557.1% | 67.0% |
| EPS (diluted) | — | $0.90 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.1M | $51.6M | ||
| Q3 25 | $52.3M | $49.1M | ||
| Q2 25 | $45.6M | $47.6M | ||
| Q1 25 | $41.5M | $37.5M | ||
| Q4 24 | $57.5M | $38.9M | ||
| Q3 24 | $51.5M | $35.1M | ||
| Q2 24 | $46.6M | $32.4M | ||
| Q1 24 | $44.9M | $29.5M |
| Q4 25 | $-44.1M | $34.8M | ||
| Q3 25 | $-5.5M | $25.4M | ||
| Q2 25 | $-5.6M | $26.0M | ||
| Q1 25 | $-11.4M | $18.9M | ||
| Q4 24 | $9.6M | $20.8M | ||
| Q3 24 | $941.0K | $15.8M | ||
| Q2 24 | $-10.4M | $14.8M | ||
| Q1 24 | $-6.2M | $17.3M |
| Q4 25 | 52.9% | — | ||
| Q3 25 | 52.7% | — | ||
| Q2 25 | 52.3% | — | ||
| Q1 25 | 48.6% | — | ||
| Q4 24 | 58.5% | — | ||
| Q3 24 | 56.3% | — | ||
| Q2 24 | 54.6% | — | ||
| Q1 24 | 51.3% | — |
| Q4 25 | -9.0% | 97.0% | ||
| Q3 25 | -17.6% | 72.1% | ||
| Q2 25 | -23.3% | 71.3% | ||
| Q1 25 | -36.1% | 71.7% | ||
| Q4 24 | 5.2% | 82.5% | ||
| Q3 24 | -8.2% | 60.6% | ||
| Q2 24 | -18.3% | 61.3% | ||
| Q1 24 | -23.9% | 78.8% |
| Q4 25 | -70.9% | 67.3% | ||
| Q3 25 | -10.5% | 51.7% | ||
| Q2 25 | -12.2% | 54.6% | ||
| Q1 25 | -27.5% | 50.4% | ||
| Q4 24 | 16.8% | 53.5% | ||
| Q3 24 | 1.8% | 45.1% | ||
| Q2 24 | -22.4% | 45.6% | ||
| Q1 24 | -13.8% | 58.5% |
| Q4 25 | — | $0.90 | ||
| Q3 25 | — | $0.65 | ||
| Q2 25 | — | $0.69 | ||
| Q1 25 | — | $0.51 | ||
| Q4 24 | — | $0.56 | ||
| Q3 24 | — | $0.44 | ||
| Q2 24 | — | $0.42 | ||
| Q1 24 | — | $0.49 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | $92.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $341.7M | $672.5M |
| Total Assets | $461.5M | $7.4B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $90.9M | $92.1M | ||
| Q3 25 | $93.3M | $99.0M | ||
| Q2 25 | $75.5M | $79.6M | ||
| Q1 25 | $95.3M | $51.7M | ||
| Q4 24 | $98.7M | $49.9M | ||
| Q3 24 | $162.3M | $44.1M | ||
| Q2 24 | $177.9M | $47.4M | ||
| Q1 24 | $168.8M | $34.8M |
| Q4 25 | $341.7M | $672.5M | ||
| Q3 25 | $378.6M | $634.3M | ||
| Q2 25 | $377.6M | $597.9M | ||
| Q1 25 | $379.6M | $563.2M | ||
| Q4 24 | $395.7M | $516.9M | ||
| Q3 24 | $385.5M | $484.6M | ||
| Q2 24 | $389.1M | $471.3M | ||
| Q1 24 | $392.6M | $452.9M |
| Q4 25 | $461.5M | $7.4B | ||
| Q3 25 | $494.9M | $7.0B | ||
| Q2 25 | $493.3M | $6.5B | ||
| Q1 25 | $482.6M | $6.0B | ||
| Q4 24 | $499.5M | $5.5B | ||
| Q3 24 | $491.2M | $5.2B | ||
| Q2 24 | $483.7M | $4.9B | ||
| Q1 24 | $492.1M | $4.6B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | $18.2M |
| Free Cash FlowOCF − Capex | $-1.8M | $17.9M |
| FCF MarginFCF / Revenue | -2.9% | 34.6% |
| Capex IntensityCapex / Revenue | 1.6% | 0.5% |
| Cash ConversionOCF / Net Profit | — | 0.52× |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | $40.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-771.0K | $18.2M | ||
| Q3 25 | $-3.9M | $11.5M | ||
| Q2 25 | $108.0K | $7.7M | ||
| Q1 25 | $-125.0K | $3.5M | ||
| Q4 24 | $2.0M | $37.8M | ||
| Q3 24 | $13.2M | $-17.6M | ||
| Q2 24 | $6.2M | $11.5M | ||
| Q1 24 | $4.0M | $10.6M |
| Q4 25 | $-1.8M | $17.9M | ||
| Q3 25 | $-4.6M | $11.4M | ||
| Q2 25 | $-1.5M | $7.6M | ||
| Q1 25 | $-974.0K | $3.5M | ||
| Q4 24 | $1.1M | $37.5M | ||
| Q3 24 | $12.2M | $-17.6M | ||
| Q2 24 | $5.2M | $11.4M | ||
| Q1 24 | $3.4M | $10.5M |
| Q4 25 | -2.9% | 34.6% | ||
| Q3 25 | -8.7% | 23.2% | ||
| Q2 25 | -3.2% | 15.9% | ||
| Q1 25 | -2.3% | 9.2% | ||
| Q4 24 | 1.9% | 96.4% | ||
| Q3 24 | 23.7% | -50.3% | ||
| Q2 24 | 11.0% | 35.1% | ||
| Q1 24 | 7.6% | 35.8% |
| Q4 25 | 1.6% | 0.5% | ||
| Q3 25 | 1.3% | 0.1% | ||
| Q2 25 | 3.5% | 0.2% | ||
| Q1 25 | 2.0% | 0.2% | ||
| Q4 24 | 1.6% | 0.7% | ||
| Q3 24 | 2.0% | 0.2% | ||
| Q2 24 | 2.3% | 0.3% | ||
| Q1 24 | 1.3% | 0.1% |
| Q4 25 | — | 0.52× | ||
| Q3 25 | — | 0.45× | ||
| Q2 25 | — | 0.29× | ||
| Q1 25 | — | 0.19× | ||
| Q4 24 | 0.21× | 1.81× | ||
| Q3 24 | 14.05× | -1.11× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.61× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
VEL
| Related Party | $19.3M | 37% |
| Nonrelated Party | $16.9M | 33% |
| Other | $15.4M | 30% |
